menu
    • menu

    Company profile for Kedrion

    NEW Drugs in Dev: 13
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kedrion SpA (“Kedrion”) is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, Primary Immune Deficiency and Rh sensitization which can lead to hemolytic disease of the fetus and newborn.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KedrionUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Kelby Street 11th Floor Fort Lee, NJ 07024
    Telephone
    Telephone
    1-201-242-8900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kedrion.us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kedrion Launches Nationwide QIVIGY Distribution in U.S
    Kedrion Launches Nationwide QIVIGY Distribution in U.S

    06 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kedrion-activates-nationwide-distribution-network-for-qivigy-in-the-us-302706187.html

    PR NEWSWIRE
    06 Mar 2026
    Share Share
    AOM Infusion Named Exclusive Specialty Pharmacy For YIMMUGO
    AOM Infusion Named Exclusive Specialty Pharmacy For YIMMUGO

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202036399/en/AOM-Infusion-Designated-a-Limited-Distribution-Network-Specialty-Pharmacy-for-YIMMUGO-Immunoglobulin-Replacement-Therapy

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    EMA Grants Orphan Status To Kedrion's Aceruloplasminemia
    EMA Grants Orphan Status To Kedrion's Aceruloplasminemia

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/european-medicines-agency-ema-grants-orphan-drug-designation-to-kedrions-plasma-derived-treatment-for-congenital-aceruloplasminemia-a-rare-genetic

    PHARMIWEB
    27 Nov 2025
    Share Share
    Advanced Infusion Care (AIC) Adds YIMMUGO® By Kedrion Biopharma
    Advanced Infusion Care (AIC) Adds YIMMUGO® By Kedrion Biopharma

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020834522/en/Advanced-Infusion-Care-AIC-Now-Offers-Kedrion-Biopharmas-YIMMUGO-Immune-Globulin-Intravenous-Human-Dira-10-Liquid

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    kedrion Biopharma's Yimmugo Now Available in The U.S
    kedrion Biopharma's Yimmugo Now Available in The U.S

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yimmugo-now-available-in-the-us-kedrion-biopharma-commercializes-a-new-ig-therapy-for-pi-302580013.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    Kedrion Bio Gets FDA Nod For Qivigy® In Primary Immunodeficiency
    Kedrion Bio Gets FDA Nod For Qivigy® In Primary Immunodeficiency

    29 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kedrion-biopharma-receives-fda-approval-for-qivigy-immune-globulin-10-iv-for-treatment-of-primary-humoral-immunodeficiency-in-adults-and-confirms-its-plan-to-increase-investments-in-the-us-throughout-its-global-operations-302569407.html

    PR NEWSWIRE
    29 Sep 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search